Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Quidel Corp (NASDAQ:QDEL)

27.33
Delayed Data
As of 3:59pm ET
 -0.05 / -0.18%
Today’s Change
16.63
Today|||52-Week Range
27.75
+27.59%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Medical Specialties
MARKET CAP
$909.2M

Company Description

Quidel Corp. engages in the development, manufacture, and market of rapid diagnostic testing solutions. Its portfolio includes immunoassays, molecular, virology, and specialty products. Immunoassay tests are for physician offices, hospital laboratories, emergency departments, pharmacies, and other urgent care or alternative site settings. Molecular diagnostics cover laboratory and other segments. Virology portfolio involves direct fluorescent assays and culture-based tests for clinical virology laboratory. Specialty products serve bone health, autoimmune, and complement research communities. The company was founded in 1979 and is headquartered in San Diego, CA.

Contact Information

Quidel Corp.
12544 High Bluff Drive
San Diego California 92130
P:(858) 552-1100
Investor Relations:
(858) 646-8023

Employees

Shareholders

Mutual fund holders46.63%
Other institutional45.00%
Individual stakeholders19.61%

Top Executives

Douglas C. BryantPresident, Chief Executive Officer & Director
Edward Kieth RussellSenior Vice President-Global Commercial Operations
Randall J. StewardCFO & Principal Accounting Officer
Werner KrollSenior Vice President-Research & Development
Michael Donald AbneySenior Vice President-Distribution